Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | FAM43A | Human | (R)-pantothenic acid | increases expression | EXP | | 6480464 | Pantothenic Acid results in increased expression of FAM43A mRNA | CTD | PMID:19397697 | FAM43A | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of FAM43A mRNA | CTD | PMID:25380136 | FAM43A | Human | 15-acetyldeoxynivalenol | increases expression | EXP | | 6480464 | 15-acetyldeoxynivalenol results in increased expression of FAM43A mRNA | CTD | PMID:23792671 | FAM43A | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of FAM43A mRNA | CTD | PMID:23019147 | FAM43A | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of FAM43A mRNA | CTD | PMID:19167446 and PMID:31614463 | FAM43A | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FAM43A mRNA | CTD | PMID:22298810 | FAM43A | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FAM43A mRNA | CTD | PMID:25445724 and PMID:30096437 | FAM43A | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR gene SNP affects the reaction [Tetrachlorodibenzodioxin results in increased expression of FAM43A mRNA] | CTD | PMID:25445724 | FAM43A | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FAM43A mRNA | CTD | PMID:21215274 and PMID:34747641 | FAM43A | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:26705709 | FAM43A | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of FAM43A mRNA | CTD | PMID:30851411 | FAM43A | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of FAM43A mRNA | CTD | PMID:37199045 | FAM43A | Human | 3-chloropropane-1,2-diol | decreases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in decreased expression of FAM43A mRNA | CTD | PMID:28522335 | FAM43A | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of FAM43A mRNA | CTD | PMID:25380136 | FAM43A | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Fam43a (Mus musculus) | 6480464 | Fenretinide results in increased expression of FAM43A mRNA | CTD | PMID:28973697 | FAM43A | Human | acetamide | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | acetamide results in increased expression of FAM43A mRNA | CTD | PMID:31881176 | FAM43A | Human | acrylamide | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of FAM43A mRNA | CTD | PMID:28959563 | FAM43A | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of FAM43A mRNA | CTD | PMID:32763439 | FAM43A | Human | afimoxifene | multiple interactions | EXP | | 6480464 | afimoxifene inhibits the reaction [Estrogens results in decreased expression of FAM43A mRNA] | CTD | PMID:21233418 | FAM43A | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of FAM43A protein | CTD | PMID:20106945 | FAM43A | Human | aflatoxin B1 | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of FAM43A mRNA | CTD | PMID:33354967 | FAM43A | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of FAM43A mRNA | CTD | PMID:33167477 | FAM43A | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of FAM43A mRNA | CTD | PMID:33212167 | FAM43A | Human | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FAM43A mRNA | CTD | PMID:32525701 | FAM43A | Human | arsane | increases expression | EXP | | 6480464 | Arsenic results in increased expression of FAM43A mRNA | CTD | PMID:27838757 | FAM43A | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of FAM43A gene | CTD | PMID:25304211 | FAM43A | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of FAM43A gene | CTD | PMID:25304211 | FAM43A | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FAM43A mRNA | CTD | PMID:32525701 | FAM43A | Human | arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of FAM43A mRNA | CTD | PMID:27838757 | FAM43A | Human | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of FAM43A promoter | CTD | PMID:23974009 | FAM43A | Human | atrazine | affects methylation | ISO | Fam43a (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of FAM43A gene | CTD | PMID:35440735 | FAM43A | Human | avobenzone | decreases expression | EXP | | 6480464 | avobenzone results in decreased expression of FAM43A mRNA | CTD | PMID:31016361 | FAM43A | Human | azathioprine | increases expression | EXP | | 6480464 | Azathioprine results in increased expression of FAM43A mRNA | CTD | PMID:22623647 | FAM43A | Human | belinostat | increases expression | EXP | | 6480464 | belinostat results in increased expression of FAM43A mRNA | CTD | PMID:26272509 | FAM43A | Human | belinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA | CTD | PMID:27188386 | FAM43A | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of FAM43A mRNA | CTD | PMID:20064835 more ... | FAM43A | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of FAM43A 3' UTR more ... | CTD | PMID:27901495 | FAM43A | Human | benzo[a]pyrene diol epoxide I | increases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20382639 | FAM43A | Human | benzo[b]fluoranthene | increases expression | ISO | Fam43a (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of FAM43A mRNA | CTD | PMID:26377693 | FAM43A | Human | Benzo[k]fluoranthene | increases expression | ISO | Fam43a (Mus musculus) | 6480464 | benzo(k)fluoranthene results in increased expression of FAM43A mRNA | CTD | PMID:26377693 | FAM43A | Human | beta-naphthoflavone | decreases expression | EXP | | 6480464 | beta-Naphthoflavone results in decreased expression of FAM43A mRNA | CTD | PMID:32858204 | FAM43A | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Fam43a (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of FAM43A mRNA | CTD | PMID:28085963 | FAM43A | Human | bisphenol A | affects expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of FAM43A mRNA | CTD | PMID:25181051 | FAM43A | Human | bisphenol A | increases expression | ISO | Fam43a (Mus musculus) | 6480464 | bisphenol A results in increased expression of FAM43A mRNA | CTD | PMID:32156529 | FAM43A | Human | bisphenol A | decreases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of FAM43A mRNA | CTD | PMID:34947998 | FAM43A | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FAM43A mRNA | CTD | PMID:29275510 | FAM43A | Human | bortezomib | decreases expression | EXP | | 6480464 | Bortezomib results in decreased expression of FAM43A mRNA | CTD | PMID:20977926 | FAM43A | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of FAM43A mRNA | CTD | PMID:26079696 | FAM43A | Human | cadmium atom | multiple interactions | ISO | Fam43a (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM43A mRNA | CTD | PMID:37325564 | FAM43A | Human | cadmium dichloride | multiple interactions | ISO | Fam43a (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM43A mRNA | CTD | PMID:37325564 | FAM43A | Human | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes and Carbon analog results in decreased expression of FAM43A mRNA | CTD | PMID:25102311 | FAM43A | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of FAM43A mRNA | CTD | PMID:27594783 | FAM43A | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of FAM43A mRNA | CTD | PMID:19320972 | FAM43A | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | FAM43A | Human | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of FAM43A mRNA | CTD | PMID:19167446 | FAM43A | Human | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of FAM43A mRNA | CTD | PMID:29523930 | FAM43A | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of FAM43A mRNA | CTD | PMID:20106945 and PMID:21632981 | FAM43A | Human | cyclosporin A | affects expression | EXP | | 6480464 | Cyclosporine affects the expression of FAM43A mRNA | CTD | PMID:25562108 | FAM43A | Human | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of FAM43A mRNA | CTD | PMID:25047013 | FAM43A | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | FAM43A | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of FAM43A mRNA | CTD | PMID:29803840 | FAM43A | Human | endosulfan | affects expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Endosulfan affects the expression of FAM43A mRNA | CTD | PMID:29391264 | FAM43A | Human | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA | CTD | PMID:19167446 | FAM43A | Human | Enterolactone | decreases expression | EXP | | 6480464 | 2 and 3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of FAM43A mRNA | CTD | PMID:19167446 | FAM43A | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of FAM43A mRNA | CTD | PMID:26272509 | FAM43A | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA | CTD | PMID:27188386 | FAM43A | Human | folic acid | decreases expression | ISO | Fam43a (Mus musculus) | 6480464 | Folic Acid results in decreased expression of FAM43A mRNA | CTD | PMID:25629700 | FAM43A | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of FAM43A mRNA | CTD | PMID:20655997 | FAM43A | Human | furan | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | furan results in increased expression of FAM43A mRNA | CTD | PMID:27387713 | FAM43A | Human | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of FAM43A mRNA | CTD | PMID:23019147 | FAM43A | Human | gentamycin | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of FAM43A mRNA | CTD | PMID:33387578 | FAM43A | Human | glycidol | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | glycidol results in increased expression of FAM43A mRNA | CTD | PMID:24395379 and PMID:24915197 | FAM43A | Human | hydroquinone | increases expression | EXP | | 6480464 | hydroquinone results in increased expression of FAM43A mRNA | CTD | PMID:31256213 | FAM43A | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of FAM43A mRNA | CTD | PMID:28903495 | FAM43A | Human | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of FAM43A mRNA | CTD | PMID:28988120 | FAM43A | Human | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of FAM43A mRNA | CTD | PMID:33647349 | FAM43A | Human | lipopolysaccharide | increases expression | ISO | Fam43a (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of FAM43A mRNA | CTD | PMID:27339419 | FAM43A | Human | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of FAM43A mRNA | CTD | PMID:24449571 | FAM43A | Human | methylisothiazolinone | increases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of FAM43A mRNA | CTD | PMID:31629900 | FAM43A | Human | N-nitrosodimethylamine | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Dimethylnitrosamine results in increased expression of FAM43A mRNA | CTD | PMID:25380136 | FAM43A | Human | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of FAM43A mRNA | CTD | PMID:22714537 | FAM43A | Human | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of FAM43A mRNA | CTD | PMID:36318118 | FAM43A | Human | oxaliplatin | multiple interactions | ISO | Fam43a (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of FAM43A mRNA | CTD | PMID:25729387 | FAM43A | Human | oxaliplatin | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | oxaliplatin results in increased expression of FAM43A mRNA | CTD | PMID:25729387 | FAM43A | Human | ozone | multiple interactions | ISO | Fam43a (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FAM43A mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FAM43A mRNA | CTD | PMID:34911549 | FAM43A | Human | panobinostat | increases expression | EXP | | 6480464 | panobinostat results in increased expression of FAM43A mRNA | CTD | PMID:26272509 | FAM43A | Human | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA | CTD | PMID:27188386 | FAM43A | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of FAM43A mRNA | CTD | PMID:29067470 | FAM43A | Human | pentanal | increases expression | EXP | | 6480464 | pentanal results in increased expression of FAM43A mRNA | CTD | PMID:26079696 | FAM43A | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of FAM43A mRNA | CTD | PMID:26272509 | FAM43A | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA | CTD | PMID:27188386 | FAM43A | Human | progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of FAM43A mRNA | CTD | PMID:20864642 | FAM43A | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of FAM43A mRNA | CTD | PMID:26079696 | FAM43A | Human | quercitrin | increases expression | EXP | | 6480464 | quercitrin results in increased expression of FAM43A mRNA | CTD | PMID:25193878 | FAM43A | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of FAM43A mRNA | CTD | PMID:30851411 | FAM43A | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of FAM43A mRNA | CTD | PMID:19167446 | FAM43A | Human | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of FAM43A mRNA | CTD | PMID:19167446 | FAM43A | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | FAM43A | Human | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FAM43A mRNA | CTD | PMID:32525701 | FAM43A | Human | sodium arsenite | decreases methylation | ISO | Fam43a (Mus musculus) | 6480464 | sodium arsenite results in decreased methylation of FAM43A gene | CTD | PMID:24118411 | FAM43A | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of FAM43A mRNA | CTD | PMID:34032870 | FAM43A | Human | sulforaphane | increases expression | EXP | | 6480464 | sulforaphane results in increased expression of FAM43A mRNA | CTD | PMID:31838189 | FAM43A | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of FAM43A mRNA | CTD | PMID:31533062 | FAM43A | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of FAM43A mRNA | CTD | PMID:31758290 | FAM43A | Human | thioacetamide | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of FAM43A mRNA | CTD | PMID:34492290 | FAM43A | Human | titanium dioxide | decreases expression | ISO | Fam43a (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of FAM43A mRNA | CTD | PMID:29264374 | FAM43A | Human | topotecan | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Topotecan results in increased expression of FAM43A mRNA | CTD | PMID:25729387 | FAM43A | Human | topotecan | multiple interactions | ISO | Fam43a (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of FAM43A mRNA | CTD | PMID:25729387 | FAM43A | Human | trichloroethene | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of FAM43A mRNA | CTD | PMID:33387578 | FAM43A | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of FAM43A mRNA | CTD | PMID:24935251 and PMID:26272509 | FAM43A | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA | CTD | PMID:27188386 | FAM43A | Human | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of FAM43A mRNA | CTD | PMID:29024780 | FAM43A | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of FAM43A mRNA | CTD | PMID:28818685 | FAM43A | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of FAM43A mRNA | CTD | PMID:25979313 | FAM43A | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM43A mRNA | CTD | PMID:27188386 | FAM43A | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FAM43A mRNA | CTD | PMID:23179753 more ... | FAM43A | Human | vinclozolin | increases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of FAM43A mRNA | CTD | PMID:23869203 | FAM43A | Human | vinclozolin | decreases expression | ISO | Fam43a (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of FAM43A mRNA | CTD | PMID:23034163 | FAM43A | Human | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of FAM43A mRNA | CTD | PMID:18593933 | FAM43A | Human | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of FAM43A mRNA | CTD | PMID:18593933 | FAM43A | Human | zoledronic acid | decreases expression | EXP | | 6480464 | zoledronic acid results in decreased expression of FAM43A mRNA | CTD | PMID:24714768 | |